Viewing Study NCT05886868


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2025-12-25 @ 3:06 PM
Study NCT ID: NCT05886868
Status: UNKNOWN
Last Update Posted: 2023-11-29
First Post: 2023-05-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors
Sponsor: Shanghai Best-Link Bioscience, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module